Beranda › Penyakit Alzheimer › Michigan
Uji klinis Penyakit Alzheimer di Michigan
15 studi untuk Penyakit Alzheimer mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
Menerima pesertaFase 4
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
Menerima pesertaFase 1
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07598370A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
Menerima pesertaFase 2
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589595Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
Menerima pesertaFase 3
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Menerima peserta
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- dan 5 lainnya
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 24 Jul 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
Menerima pesertaFase 3
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 45 hingga 85 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 60 hingga 90 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06584357Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.